The Lancet Haematology

1. Correction to Lancet Haematol 2023; 10: e246–47

   Publication date: Available online 6 June 2023

   Source: The Lancet Haematology

   Author(s):

2. Alloimmunisation against red blood cells in sickle cell disease: transfusion challenges in high-income and low-income countries

   Publication date: June 2023

   Source: The Lancet Haematology, Volume 10, Issue 6

   Author(s): France Pirenne, Aline Floch, Saliou Diop

3. Immunochemotherapy for life-threatening haematological malignancies in pregnancy: a systematic review of the literature and cross-sectional analysis of clinical trial eligibility

   Publication date: June 2023

   Source: The Lancet Haematology, Volume 10, Issue 6

   Author(s): Georgia S Mills, Verity Chadwick, Catherine Tang, Jacinta Perram, Mary Ann Anderson, Antoinette Anazodo, Giselle Kidson-Gerber, Antonia Shand, Orly Lavee, Barbara Withers, Sam Milliken, Pietro R Di Ciaccio, Nada Hamad

4. Effect of rituximab on immune status in children with mature B-cell non-Hodgkin lymphoma: a prespecified secondary analysis of the Inter-B-NHL Ritux 2010 trial

   Publication date: June 2023

   Source: The Lancet Haematology, Volume 10, Issue 6

   Author(s): Sarah Alexander, Anne Aupérin, Simon Bomken, Monika Csóka, Bernarda Kazanowska, Alan K Chiang, Mara Andres, Anne Uyttebroeck, G A Amos Burke, József Zsiros, Marta Pillon, Catherine M Bollard, Lara Mussolin, Jaime Verdu-Amoros, Bénédicte Neven, Donald A Barkauskas, Keith Wheatley, Catherine Patte, Thomas G Gross, Véronique Minard-Colin

5. Mini-hyper-CVD plus inotuzumab ozogamicin, with or without blinatumomab, in the subgroup of older patients with newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: long-term results of an open-label phase 2 trial

   Publication date: June 2023

   Source: The Lancet Haematology, Volume 10, Issue 6

   Author(s): Elias Jabbour, Nicholas J Short, Jayastu Senapati, Nitin Jain, Xuelin Huang, Naval Daver, Courtney D DiNardo, Naveen Pemmaraju, William Wierda, Guillermo Garcia-Manero, Guillermo Montalban Bravo, Koji Sasaki, Tapan M Kadia, Joseph Khoury, Sa A Wang, Fadi G Haddad, Jovitta Jacob, Rebecca Garris, Farhad Ravandi, Hagop M Kantarjian

6. Nelarabine, intensive L-asparaginase, and protracted intrathecal therapy for newly diagnosed T-cell acute lymphoblastic leukaemia in children and young adults (ALL-T11): a nationwide, multicenter, phase 2 trial including randomisation in the very high-risk group

   Publication date: June 2023

   Source: The Lancet Haematology, Volume 10, Issue 6

   Author(s): Atsushi Sato, Yoshihiro Hatta, Chihaya Imai, Koichi Oshima, Yasuhiro Okamoto, Takao Deguchi, Yoshiko Hashii, Takashi Fukushima, Toshinori Hori, Nobutaka Kiyokawa, Motohiro Kato, Shoji Saito, Kenichi Anami, Tatsuhiro Sakamoto, Yoshiyuki Kosaka, Souichi Suenobu, Toshihiko Imamura, Akiko Kada, Akiko M Saito, Atsushi Manabe

7. Sovleplenib (HMPL-523), a novel Syk inhibitor, for patients with primary immune thrombocytopenia in China: a randomised, double-blind, placebo-controlled, phase 1b/2 study

   Publication date: June 2023

   Source: The Lancet Haematology, Volume 10, Issue 6

   Author(s): Xiaofan Liu, Hu Zhou, Yu Hu, Jie Yin, Junmin Li, Wenming Chen, Ruibin Huang, Yuping Gong, Chengwei Luo, Heng Mei, Bingjie Ding, Chengyuan Gu, Huiping Sun, Yun Leng, Dexiang Ji, Yan Li, Hongyan Yin, Haiyan Shi, Keyan Chen, Jian Wang

8. 49th annual meeting of the EBMT

   Publication date: June 2023

   Source: The Lancet Haematology, Volume 10, Issue 6

   Author(s): Yaiza del Pozo Martín

9. Correction to Lancet Haematol 2023; 10: e445–57

   Publication date: June 2023

   Source: The Lancet Haematology, Volume 10, Issue 6

   Author(s):

10. Correction to Lancet Haematol 2023; 10: e419–32

    Publication date: June 2023

    Source: The Lancet Haematology, Volume 10, Issue 6

    Author(s):

11. Correction to Lancet Haematol 2023; 10: e250–60

    Publication date: June 2023

    Source: The Lancet Haematology, Volume 10, Issue 6

    Author(s):

12. Correction to Lancet Haematol 2023; 10: e246–47

    Publication date: June 2023

    Source: The Lancet Haematology, Volume 10, Issue 6

    Author(s):

13. Appropriate use of sex and gender for diversity, equity, and inclusion in biomedical research

    Publication date: June 2023

    Source: The Lancet Haematology, Volume 10, Issue 6

    Author(s): Lorin A Bibb, Jeremy W Jacobs, Brian D Adkins, Jennifer S Woo, Laura D Stephens, Garrett S Booth

14. Long-term sequelae after immunotherapeutic approaches in haematological malignancies—what do we know?

    Publication date: June 2023

    Source: The Lancet Haematology, Volume 10, Issue 6

    Author(s): Gabriele Escherich, Rachael Hough

15. Balancing toxicity and effectiveness in older adults with B-cell acute lymphocytic leukaemia

    Publication date: June 2023

    Source: The Lancet Haematology, Volume 10, Issue 6

    Author(s): Emily Curran

16. Nelarabine and optimisation of therapy for T-cell acute lymphoblastic leukaemia

    Publication date: June 2023

    Source: The Lancet Haematology, Volume 10, Issue 6

    Author(s): Niharendu Ghara, Vaskar Saha

17. Expanding therapeutic options for patients with primary immune thrombocytopenia

    Publication date: June 2023

    Source: The Lancet Haematology, Volume 10, Issue 6

    Author(s): Maria L Lozano

18. Celebrating blood donors amid advances in blood transfusion

    Publication date: June 2023

    Source: The Lancet Haematology, Volume 10, Issue 6

    Author(s): The Lancet Haematology

19. Mental health disorders and survival among older patients with diffuse large B-cell lymphoma in the USA: a population-based study

    Publication date: Available online 1 June 2023

    Source: The Lancet Haematology

    Author(s): Thomas M Kuczmarski, Angela C Tramontano, Lee Mozessohn, Ann S LaCasce, Lizabeth Roemer, Gregory A Abel, Oreofe O Odejide

20. Could improving mental health disorders help increase cancer survival?

    Publication date: Available online 1 June 2023

    Source: The Lancet Haematology

    Author(s): Elizabeth A Davies, Yueh-Hsin Wang

21. CPX-351 in higher risk myelodysplastic syndrome and chronic myelomonocytic leukaemia: a multicentre, single-arm, phase 2 study

    Publication date: Available online 25 May 2023

    Source: The Lancet Haematology

    Author(s): Pierre Peterlin, Yannick Le Bris, Pascal Turlure, Patrice Chevallier, Audrey Ménard, Marie-Pierre Gourin, Pierre-Yves Dumas, Sylvain Thepot, Ana Berceanu, Sophie Park, Marie-Anne Hospital, Thomas Cluzeau, Simon Bouzy, Jose-Miguel Torregrosa-Diaz, Louis Drevon, Rosa Sapena, Fatiha Chermat, Lionel Ades, Sophie Dimicoli-Salazar, Sylvie Chevret

22. CPX-351 for higher risk myelodysplastic syndrome: cytarabine and daunorubicin in disguise?

    Publication date: Available online 25 May 2023

    Source: The Lancet Haematology

    Author(s): Petra Muus, Theo de Witte

23. Correction to Lancet Haematol 2023; 10: e333–45

    Publication date: Available online 19 May 2023

    Source: The Lancet Haematology

    Author(s):

24. Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09–09): a randomised, open-label, multicentre, phase 3 trial

    Publication date: Available online 12 May 2023

    Source: The Lancet Haematology

    Author(s): Hartmut Döhner, Daniela Weber, Julia Krzykalla, Walter Fiedler, Michael W M Kühn, Thomas Schroeder, Karin Mayer, Michael Lübbert, Mohammed Wattad, Katharina Götze, Lars Fransecky, Elisabeth Koller, Gerald Wulf, Jan Schleicher, Mark Ringhoffer, Richard Greil, Bernd Hertenstein, Jürgen Krauter, Uwe M Martens, David Nachbaur

25. Time to add gemtuzumab ozogamicin to intensive chemotherapy for NPM1-mutated acute myeloid leukaemia?

    Publication date: Available online 12 May 2023

    Source: The Lancet Haematology

    Author(s): Jad Othman, Richard Dillon

26. Using immunotherapy and novel trial designs to optimise front-line therapy in adult acute lymphoblastic leukaemia: breaking with the traditions of the past

    Publication date: May 2023

    Source: The Lancet Haematology, Volume 10, Issue 5

    Author(s): Nicholas J Short, Hagop Kantarjian

27. European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours

    Publication date: May 2023

    Source: The Lancet Haematology, Volume 10, Issue 5

    Author(s): Cristina Nanni, Carsten Kobe, Bettina Baeßler, Christian Baues, Ronald Boellaard, Peter Borchmann, Andreas Buck, Irène Buvat, Björn Chapuy, Bruce D Cheson, Robert Chrzan, Ann-Segolene Cottereau, Ulrich Dührsen, Live Eikenes, Martin Hutchings, Wojciech Jurczak, Françoise Kraeber-Bodéré, Egesta Lopci, Stefano Luminari, Steven MacLennan

28. Incidence and prognosis of superficial vein thrombosis during pregnancy and the post-partum period: a Danish nationwide cohort study

    Publication date: May 2023

    Source: The Lancet Haematology, Volume 10, Issue 5

    Author(s): Hanke M G Wiegers, Dóra Körmendiné Farkas, Erzsébet Horváth-Puhó, Saskia Middeldorp, Nick van Es, Henrik T Sørensen

29. Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial

    Publication date: May 2023

    Source: The Lancet Haematology, Volume 10, Issue 5

    Author(s): Christopher Melani, Kennichi Dowdell, Stefania Pittaluga, Kieron Dunleavy, Mark Roschewski, Joo Y Song, Sara Calattini, Jun-ichi Kawada, David A Price, Pratip K Chattopadhyay, Mario Roederer, Andrea N Lucas, Seth M Steinberg, Elaine S Jaffe, Jeffrey I Cohen, Wyndham H Wilson

30. Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trial

    Publication date: May 2023

    Source: The Lancet Haematology, Volume 10, Issue 5

    Author(s): Stephan A Grupp, Selim Corbacioglu, Hyoung Jin Kang, Takanori Teshima, Seong Lin Khaw, Franco Locatelli, Johan Maertens, Matthias Stelljes, Polina Stepensky, Paty Lopez, Vian Amber, Antonio Pagliuca, Paul G Richardson, Mohamad Mohty